G2 is a world-renowned platform for evaluating business solutions, which derives its scores from reviews and ratings, among other metrics, provided by verified users. The rankings offer valuable insights into user experiences and are significant to Viedoc clients and those considering Viedoc for their clinical studies. For a product to feature in the report, it needs to receive a minimum of ten reviews in a chosen category and in this context, Viedoc stands out, scoring in the top 3 in most of its segments.
Viedoc is mentioned in more reports than ever before and has proudly retained all its badges from last season, solidifying its position as a frontrunner in the industry. Once again, Viedoc is recognized as #1 in the Momentum Grid Report for Electronic Data Capture. Momentum scores are based on social, web, employee, and review data that G2 deems influential in a company’s progress. Badges within this segment are awarded to products with the top Momentum Grid scores and this season, Viedoc continues to lead.
This spring, Viedoc secures its presence in yet another significant G2 report: the Small-Business Relationship Index for Electronic Data Capture. This latest inclusion speaks volumes about Viedoc's unwavering commitment to quality and user satisfaction. The report recognizes products not just for their performance, but for fostering meaningful relationships with their users. Viedoc stands out among its competitors, having received a substantial number of reviews and responses from verified users in each of the relationship-related questions featured in G2’s review form. Viedoc’s solid Relationship score reflects our dedication to providing top-notch support, seamless user experiences, and unparalleled ease of doing business.
Viedoc upholds three noteworthy positions in the Asia Pacific and India segments:
Products featured in these segments are evaluated based on customer satisfaction and regional market presence. As for Viedoc, which is positioned in the Leader quadrant, it entails that the software is rated highly by G2 users in the Asia region and exhibits significant Market Presence scores.
As a leading provider of eClinical software solutions for clinical trials worldwide, Viedoc Technologies is strategically extending its footprint across multiple markets in response to escalating demand. In 2023, 37% of Viedoc's new global clientele hailed from the United States, reflecting the company's intent to leverage the expanding US clinical trials sector, projected to exceed $35.1 billion by 2030. Notably, Viedoc has achieved a remarkable 33,5% revenue surge in the US market over the past year, underscoring its strong growth trajectory in this industry segment.
In support of its growth strategy, Viedoc has undertaken several key initiatives. These include setting up a dedicated US headquarters, appointing a Chief Marketing Officer to enhance Viedoc's outreach in the US market, aligning its data privacy protocols with US standards (augmenting its ISO 27001 certification with a SOC2 assessment), and expanding its service delivery capacity through a Software as a Service (SaaS) operational framework. Furthermore, Viedoc proudly maintains the latest ISO 27001:2022 certification, demonstrating its commitment to data security and compliance.
We are honored to be recognized as a G2 Spring 2024 Leader and highly value our users' feedback. Feel free to share your experience by leaving a review on G2.
Curious to learn more about our eClinical solutions? Request a demo!
"Viedoc makes building a study easy and fun. It doesn't require extensive coding knowledge; it's quick to get in and start working."
